In its lawsuit, Aetna claimed Insys defrauded the insurer into paying claims for Subsys. Subsys is an opioid that is supposed to only be prescribed to people with cancer, but was used for other purposes, according to Aetna.
The ruling from U.S. District Judge Cynthia Rufe in Philadelphia was made in one of several lawsuits health insurers have filed against Insys. The lawsuits follow U.S. investigations into how Insys promoted Subsys. Prosecutors accused the drugmaker of paying physicians millions of dollars to prescribe the opioids in an alleged kickback scheme, according to The New York Times Magazine.
More articles on pharmacy:
Blood pressure drug recalled after labeling mix-up
Narcan maker to be acquired by Emergent Biosolutions for $735M
US-Mexico trade deal grants drugmakers 10 years of patent exclusivity on biologics
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
